Long COVID and ME/CFS: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• IL-6 1
• ACE2 0
• mTOR 0
• NLRP3 0
• PI3K 0
• TNF 0
• AMPK 0
• CD38 1
• GLP-1 0
• IL-15 1
• MMP-9 0
• AKT 0
• APOE 0
• AQP4 0
• BDNF 0
• CD19 1
• CD40 0
• HIF-1 0
• HSP90 0
• IL-1 0
• IL-17 0
• JAK 0
• NMDA 0
• PD-1 1
• SGLT2 0
• TFEB 0
• TP53 0
• VEGF 0

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 936 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Suspended

  A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

  NCT04031469· ProgenaBiome· Updated 21 Sept 2026

  “Administrative”Registry text, quoted unchanged. Source

• Terminated

  Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data

  NCT05876377· Pfizer· Updated 15 Sept 2026

  “Study discontinued due to questions of data validity and bias in data which would limit causal inference and estimation of vaccine effectiveness.”Registry text, quoted unchanged. Source

• Withdrawn

  REVERSE-Long COVID-19 With Baricitinib Study

  NCT05858515· Vanderbilt University Medical Center· Updated 9 Sept 2026

  “This submission for the pilot study has been withdrawn as the full trial opened under a different NCT number before participants enrolled in the pilot.”Registry text, quoted unchanged. Source

• Terminated

  CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19

  NCT05530317· University of California, San Francisco· Updated 13 Aug 2026

  “PI changed institutions, exploring restarting at new institution”Registry text, quoted unchanged. Source

• Withdrawn

  Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID

  NCT07714889· Toivoa Inc· Updated 29 Jul 2026

  “This study does not meet the clinical trial definition under FDAAA 801 / NIH policy - participants aren't prospectively assigned to an intervention, and no biomedical or behavioral outcome is evaluated.”Registry text, quoted unchanged. Source

• Withdrawn

  Education of Medical Staff to Post Acute Covid susTained sYmptoms

  NCT06082258· Assistance Publique - Hôpitaux de Paris· Updated 1 Jul 2026

  “The research was not feasible due to administrative and organizational constraints.”Registry text, quoted unchanged. Source

• Terminated

  Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation

  NCT05967052· National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland· Updated 17 Jun 2026

  “occurrence of scientific risk”Registry text, quoted unchanged. Source

• Suspended

  Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.

  NCT03807973· University of Alabama at Birmingham· Updated 2 Jun 2026

  “Lost funding.”Registry text, quoted unchanged. Source

• Terminated

  Functional and Affective Effects of a Brief tDCS Intervention in Fibromyalgia and Chronic Fatigue Syndrome

  NCT07573709· Hospital Donostia· Updated 7 May 2026

  “Not stopped. It is completed.”Registry text, quoted unchanged. Source

• Terminated

  Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)

  NCT05986422· Charite University, Berlin, Germany· Updated 5 May 2026

  “Following a recommendation from the Data Safety Monitoring Board (DSMB).”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)

  NCT07388550· National Institute of Neurological Disorders and Stroke (NINDS)· Source

• Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study

  NCT07874217· Oxford Brookes University· Source

• LIFT: Life Improvement Trial

  NCT06366724· Brigham and Women's Hospital· Source

• The Precision Mito- Mito Map COMPASS Study

  NCT07856121· AI Agent Vault, Inc. d/b/a Precision Mito· Source

• Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI

  NCT05615415· NYU Langone Health· Source

• Heat thErapy And mobiLity in COVID-19 Survivors

  NCT06928116· University of Nebraska· Source

• Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA

  NCT06503939· Xiangya Hospital of Central South University· Source

• RCT of Efficacy and Safety of CP003 on CFS/ME or Post COVID-19 Fatigue

  NCT06739720· The University of Hong Kong· Source

• Autoimmune Intervention Mastery Course Study

  NCT05057676· Terry L. Wahls· Source

• Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19

  NCT06821087· University of Texas at Austin· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 7
• Organoids 1
• Mendelian Randomization Analysis 4
• Gene Expression Profiling 20
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 6
• Proteomics 40
• Metabolomics 20
• Mass Spectrometry 1
• Flow Cytometry 2
• Immunohistochemistry 2
• Positron-Emission Tomography 9
• Magnetic Resonance Imaging 49
• Machine Learning 32
• Deep Learning 5
• Cohort Studies 91
• Genome-Wide Association Study 11

See which targets of this disease your abstract mentions, and go to the people working on them.